In the last trading session, 4.58 million shares of the Solid Biosciences Inc (NASDAQ:SLDB) were traded, and its beta was 2.13. Most recently the company’s share price was $3.44, and it changed around $0.56 or 19.44% from the last close, which brings the market valuation of the company to $137.44M. SLDB currently trades at a discount to its 52-week high of $15.05, offering almost -337.5% off that amount. The share price’s 52-week low was $2.88, which indicates that the current value has risen by an impressive 16.28% since then. We note from Solid Biosciences Inc’s average daily trading volume that its 10-day average is 0.46 million shares, with the 3-month average coming to 441.59K.
Solid Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.09. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended SLDB as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Solid Biosciences Inc is expected to report earnings per share of -0.78 for the current quarter.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Instantly SLDB has showed a green trend with a performance of 19.44% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.97 on recent trading dayincreased the stock’s daily price by 13.35%. The company’s shares are currently down -14.00% year-to-date, but still up 9.21% over the last five days. On the other hand, Solid Biosciences Inc (NASDAQ:SLDB) is -14.64% down in the 30-day period. We can see from the shorts that 2.33 million shares have been sold at a short interest cover period of 4.23 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 81.89% from its current value. Analyst projections state that SLDB is forecast to be at a low of $12 and a high of $20.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 32.21%. Solid Biosciences Inc earnings are expected to increase by 40.08% in 2025, but the outlook is positive 16.75% per year for the next five years.
SLDB Dividends
Solid Biosciences Inc’s next quarterly earnings report is expected to be released in March.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.85% of Solid Biosciences Inc shares, and 90.90% of them are in the hands of institutional investors. The stock currently has a share float of 91.69%.
